Tian Xiaofeng graduated from University with doctor degree in law.
Mr. Tian has worked in Jingtian & Gongcheng since 2024. Prior to this, he worked in Boss & Young Attorney-at-law for 9 years as partner.
Mr. Tian specializes in anti-trust, anti-unfair competition, anti-corruption, advertisement law, and product quality and protection of consumers’ rights. LegalBand ranks Mr. Tian as Top 15 Compliance Versatile Practitioners in 2021, and he was awarded China’s Top 100 Lawyers by China Business Law Journal in 2021.
In the area of anti-trust, Mr. Tian has provided legal services to many companies in respect of government investigation response, notification of concentration of undertakings and establishment of Antitrust compliance system，such companies including Huafeng Group,KSPG, Glodon etc.
In the area of anti-unfair competition, Mr. Tian has provided legal services to many companies in respect of protection of trade secrets and Establishment of compliance system, protection from commercial defamation or commercial confusion acts，such companies including Philips, CHIESI, Fosun Kite and Sulzer etc.
In the area of anti-corruption, Mr. Tian has provided legal services to many companies in respect of internal audit and compliance system establishment and investigation response.
In the area of advertisement law, Mr. Tian has provided legal services to many companies in respect of advertising review and advertising compliance training，such companies including CHIESI, AbbVie, Besins, Shuotang, L'Oréal, L'Occitane, Michelin, FERRERO etc.
In the area of product quality and protection of consumers’ rights, Mr. Tian has provided legal services to many companies in respect of consumer complaint handling. His main clients include a number of well-known enterprises at home and abroad.
Mr. Tian was admitted to PRC bar in 1999.
Education Background
Harvard University, Visiting scholar
Fudan University, PHD
Northwest University of Political Science and Law, Master in law
NorthWest University, Bachelor of law
Career Experience
Jingtian & Gongcheng, Partner
Boss&Young attorney-at-law, Partner
Fair Trade Office of SHAIC, Government lawyer
Inspection Detachment of Putuo Administration for Industry and Commerce, Vice captain
Professional Qualifications
Lawyers License People’s Republic of China
Social Activities
All China Lawyers Association, Deputy Director of the Anti-Monopoly and Anti-Unfair Competition Professional Committee
Shanghai Bar Association, Director of the Competition and Anti-Monopoly Professional Committee
Shanghai Law Society, Council member of the Competition Law Research Association
Shanghai Administration for Market Regulation, Member of the Anti-Monopoly Expert Group
Shanghai Administration for Market Regulation, Legal Counsel
Member of the Fair Competition Review and Competition Law Expert Database of Shenzhen
Expert of the third-party supervision and evaluation mechanism for compliance of enterprises involved in legal cases in Putuo District
Member of the Intellectual Property Protection Expert Group of Jiading District
Member of the Fair Competition Review Expert Group of Huzhou
Provided legal advisory services to numerous renowned domestic and international companies, including Sinopharm, Philips, CHIESI, Fosun Kite, Michelin, FERRERO, HEINZ, Pinduoduo, L'Oreal, L'Occitane, Friesland Campina, JLR, Booking, Brother，etc.
Anti-trust：Represented famous enterprises such as Huafeng Group，KSPG in dozens of concentration notification cases. Provided legal services in anti-trust investigation and responses to state-owned enterprises, listed pharmaceutical enterprises, Internet enterprises and other large enterprises. Offered legal services in anti-unfair competition compliance consulting and business policy formulation for companies such as Sinopharm, Baxter, Shanghai United Assets And Equity Exchange, Opple, FERRERO, SKF, SCA, Avon, Michelin, Jaguar, and Glodon.
Anti-unfair competition: Provided anti-unfair competition legal services for many domestic and overseas companies such as Philips, Fosun Kate, Sulzer, CHIESI, Friesland Campina and Pinduoduo, etc.
Anti-corruption: Conducted internal audit investigations for several multinational pharmaceutical companies regarding their suppliers and key personnel, assisting in establishing internal audit and compliance systems. Assited several domestic and foreign pharmaceutical enterprises in responding to anti-corruption investigations. Assisted foreign enterprises and their senior executives in responding to FCPA investigations.
Advertisement Compliance: Provided advertising compliance review, investigation response and training services for renowned companies such as L'Oreal, L'Occitane, Lisi, JLR，Booking, Friesland Campina, Vitasoy, etc.
Consumer Protection: Provided many famous enterprises with investigation response services, including those on product quality, premium sales, and consumer complaints.
Research on the Frontier Issues of Foreign-related Legal Affairs-Identification of Commercial Bribery Acts and Improvement of Enterprise Compliance System under the Anti-unfair Competition Law, Published in 2022
Brief Introduction：In order to regulate commercial activities, reduce the risk of violations of commercial bribery (especially commercial bribery among pharmaceutical enterprises), and provide guidance for enterprises to in compliance, the author strive to achieve the following objectives through this article:(1)Clarifying identification standards for commercial bribery under the Anti-unfair Competition Law. On this basis, analyzing the status quo of administrative enforcement of commercial bribery laws in our country, and putting forward relevant suggestions on improving commercial bribery clauses in light of the Anti-Unfair Competition Law (Revised Draft for Comment).(2) Through case study, we can point out common circumstances of commercial bribery conducts in the medicine industry. We can also explore approaches to improve the anti- commercial bribery compliance system of multinational pharmaceutical enterprises in combination with some other special provisions applicable to multinational pharmaceutical enterprises, such as FCPA and RDPAC Code of Practice 2022
2022.6，Brief Review of the New AML, Published on Wolters Kluwer
2022.6，Risk of Creative Marketing Advertising I, Published on Wolters Kluwer
2022.6，Risk of Creative Marketing Advertising II, Published on Wolters Kluwer
2022.6，Overview on Provisions for the Clear Marketing of Prices and the Prohibition of Price Fraud, Published on Wolters Kluwer
2022.5，Anti-Unfair Competition Law and its role in intellectual property protection - a brief comment on two trademark infringement cases in the Supreme Court, Published on Wolters Kluwer
2021.5，Review of Guidelines for Antitrust in the Platform Economy (Draft for Comment), Published on Shanghai Lawyer
2020.11，Key points of the Interim Provisions on Regulating Sales Promotions summary, Published on Wolters Kluwer
2020.5，Legal Issues of Price Rising Behavior during quarantine caused by COVID-19, Published on Market Regulation
2018.3，Assessment of the legal risks of commercial bribery arising from pharmaceutical enterprises sponsoring academic conferences, Published on China Market Regulation news
